Persistent Impairment of Quality of Life in Patients with Herpes Simplex Keratitis

Ophthalmology

Volumn 124, Issue 2, 2017, Pages 160-169

  Reynaud, Clotilde ^a   Rousseau, Antoine ^a,b   Kaswin, Godefroy ^a   M'garrech, Mohamed ^a   Barreau, Emmanuel ^a   Labetoulle, Marc ^a,b  

^a BICÊTRE HOSPITAL   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADULT; AGE; AGED; ANTIVIRAL THERAPY; CLINICAL ARTICLE; COLOR VISION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; EVALUATION STUDY; EYE PAIN; FEMALE; GLAUCOMA; GLAUCOMA QUALITY OF LIFE 17; HERPES SIMPLEX KERATITIS; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INFECTION PREVENTION; MALE; MENTAL HEALTH; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; OCULAR SURFACE DISEASE; OCULAR SURFACE DISEASE QUALITY OF LIFE; PERIPHERAL VISION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; QUESTIONNAIRE; RELAPSE; SELF CONCEPT; SOCIAL STATUS; VISUAL ACUITY; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; PSYCHOLOGY; SICKNESS IMPACT PROFILE; UNITED STATES; VIROLOGY; VISUAL DISORDER;

AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; KERATITIS, HERPETIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; SURVEYS AND QUESTIONNAIRES; UNITED STATES; VISION DISORDERS; VISUAL ACUITY;

EID: 85006757546     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2016.10.001     Document Type: Conference Paper

References (44)

1. 1 Kaye, S., Choudhary, A., Herpes simplex keratitis. Prog Retin Eye Res 25 (2006), 355–380.
2. 2 Rowe, A.M., St Leger, A.J., Jeon, S., et al. Herpes keratitis. Prog Retin Eye Res 32 (2013), 88–101.
3. 3 Liesegang, T.J., Melton, L.J. III, Daly, P.J., Ilstrup, D.M., Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 107 (1989), 1155–1159.
4. 4 Labetoulle, M., Auquier, P., Conrad, H., et al. Incidence of herpes simplex virus keratitis in France. Ophthalmology 112 (2005), 888–895.
5. 5 Young, R.C., Hodge, D.O., Liesegang, T.J., Baratz, K.H., Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976-2007: the effect of oral antiviral prophylaxis. Arch Ophthalmol 128 (2010), 1178–1183.
6. 6 Farooq, A.V., Shukla, D., Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol 57 (2012), 448–462.
7. 7 Liesegang, T.J., Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 107 (1989), 1160–1165.
8. 8 Wishart, M.S., Darougar, S., Viswalingam, N.D., Recurrent herpes simplex virus ocular infection: epidemiological and clinical features. Br J Ophthalmol 71 (1987), 669–672.
9. 9 Darougar, S., Wishart, M.S., Viswalingam, N.D., Epidemiological and clinical features of primary herpes simplex virus ocular infection. Br J Ophthalmol 69 (1985), 2–6.
10. 10 Liesegang, T.J., Herpes simplex virus epidemiology and ocular importance. Cornea 20 (2001), 1–13.
11. 11 Kabra, A., Lalitha, P., Mahadevan, K., et al. Herpes simplex keratitis and visual impairment: a case series. Indian J Ophthalmol 54 (2006), 23–27.
12. 12 Kaswin, G., Rousseau, A., M'Garrech, M., et al. Optical aberrations in patients with recurrent herpes simplex keratitis and apparently normal vision. Br J Ophthalmol 97 (2013), 1113–1117.
13. 13 Knickelbein, J.E., Hendricks, R.L., Charukamnoetkanok, P., Management of herpes simplex virus stromal keratitis: an evidence-based review. Surv Ophthalmol 54 (2009), 226–234.
14. 14 M'Garrech, M., Rousseau, A., Kaswin, G., et al. Impairment of lacrimal secretion in the unaffected fellow eye of patients with recurrent unilateral herpetic keratitis. Ophthalmology 120 (2013), 1959–1967.
15. 15 Stern, M.E., Gao, J., Siemasko, K.F., et al. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res 78 (2004), 409–416.
16. 16 Hamrah, P., Cruzat, A., Dastjerdi, M.H., et al. Corneal sensation and subbasal nerve alterations in patients with herpes simplex keratitis: an in vivo confocal microscopy study. Ophthalmology 117 (2010), 1930–1936.
17. 17 Rousseau, A., Nasser, G., Chiquet, C., et al. Diffusion tensor magnetic resonance imaging of trigeminal nerves in relapsing herpetic keratouveitis. PLoS One, 10, 2015, e0122186.
18. 18 Hoeksema, L., Los, L.I., Vision-related quality of life in herpetic anterior uveitis patients. PLoS One, 9, 2014, e85224.
19. 19 Li, Y., Hong, J., Wei, A., et al. Vision-related quality of life in patients with infectious keratitis. Optom Vis Sci 91 (2014), 278–283.
20. 20 Mangione, C.M., Berry, S., Spritzer, K., et al. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol 116 (1998), 227–233.
21. 21 Mangione, C.M., Lee, P.P., Pitts, J., et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol 116 (1998), 1496–1504.
22. 22 Nordmann, J.P., Viala, M., Sullivan, K., et al. Psychometric validation of the National Eye Institute Visual Function Questionnaire – 25 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucoma. Pharmacoeconomics 22 (2004), 197–206.
23. 23 Zanlonghi, X., Arnould, B., Bechetoille, A., et al. [Glaucoma and quality of life]. J Fr Ophtalmol 26 Spec No 2 (2003), S39–S44.
24. 24 Bechetoille, A., Arnould, B., Bron, A., et al. Measurement of health-related quality of life with glaucoma: validation of the Glau-QoL 36-item questionnaire. Acta Ophthalmol 86 (2008), 71–80.
25. 25 Baudouin, C., Creuzot-Garcher, C., Hoang-Xuan, T., et al. Severe impairment of health-related quality of life in patients suffering from ocular surface diseases. J Fr Ophtalmol 31 (2008), 369–378.
26. 26 Chucair-Elliott, A.J., Zheng, M., Carr, D.J., Degeneration and regeneration of corneal nerves in response to HSV-1 infection. Invest Ophthalmol Vis Sci 56 (2015), 1097–1107.
27. 27 Teoli, D.A., Smith, M.D., Leys, M.J., et al. Visual function affects prosocial behaviors in older adults. Int Ophthalmol 36 (2016), 45–54.
28. 28 Zebardast, N., Swenor, B.K., van Landingham, S.W., et al. Comparing the impact of refractive and nonrefractive vision loss on functioning and disability: the Salisbury eye evaluation. Ophthalmology 122 (2015), 1102–1110.
29. 29 Vashist, P., Gupta, N., Tandon, R., et al. Population-based assessment of vision-related quality of life in corneal disease: results from the CORE study. Br J Ophthalmol 100 (2016), 588–593.
30. 30 Le, Q., Cui, X., Xiang, J., et al. Impact of conjunctivochalasis on visual quality of life: a community population survey. PLoS One, 9, 2014, e110821.
31. 31 Vitale, S., Goodman, L.A., Reed, G.F., Smith, J.A., Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjogren's syndrome-related dry eye. Health Qual Life Outcomes, 2, 2004, 44.
32. 32 Saboo, U.S., Amparo, F., Abud, T.B., et al. Vision-related quality of life in patients with ocular graft-versus-host disease. Ophthalmology 122 (2015), 1669–1674.
33. 33 Ni, W., Li, X., Hou, Z., et al. Impact of cataract surgery on vision-related life performances: the usefulness of Real-Life Vision Test for cataract surgery outcomes evaluation. Eye (Lond) 29 (2015), 1545–1554.
34. 34 Hirneiss, C., Schmid-Tannwald, C., Kernt, M., et al. The NEI VFQ-25 vision-related quality of life and prevalence of eye disease in a working population. Graefes Arch Clin Exp Ophthalmol 248 (2010), 85–92.
35. 35 Aydin Kurna, S., Altun, A., Gencaga, T., et al. Vision related quality of life in patients with keratoconus. J Ophthalmol, 2014, 2014, 694542.
36. 36 Sakai, T., Watanabe, H., Kuroyanagi, K., et al. Health- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitis. Br J Ophthalmol 97 (2013), 338–342.
37. 37 Mitchell, P., Massin, P., Bressler, S., et al. Three-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study. Curr Med Res Opin, 2015, 1–9.
38. 38 Granstrom, T., Forsman, H., Leksell, J., et al. Visual functioning and health-related quality of life in diabetic patients about to undergo anti-vascular endothelial growth factor treatment for sight-threatening macular edema. J Diabetes Complications 29 (2015), 1183–1190.
39. 39 Chahin, S., Miller, D., Sakai, R.E., et al. Relation of quantitative visual and neurologic outcomes to fatigue in multiple sclerosis. Mult Scler Relat Disord 4 (2015), 304–310.
40. 40 Stock, M.V., Vollman, D.E., Baze, E.F., et al. Functional visual improvement after cataract surgery in eyes with age-related macular degeneration: results of the ophthalmic surgical outcomes data project. Invest Ophthalmol Vis Sci 56 (2015), 2536–2540.
41. 41 Inoue, M., Arakawa, A., Yamane, S., Kadonosono, K., Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life. Clin Ophthalmol 8 (2014), 1711–1716.
42. 42 Siqueira, R.C., Messias, A., Messias, K., et al. Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells (Reticell-clinical trial). Stem Cell Res Ther, 6, 2015, 29.
43. 43 Cortina, M.S., Hallak, J.A., Vision-related quality-of-life assessment using NEI VFQ-25 in patients after Boston keratoprosthesis implantation. Cornea 34 (2015), 160–164.
44. 44 Baudouin, C., Aragona, P., Van Setten, G., et al. Diagnosing the severity of dry eye: a clear and practical algorithm. Br J Ophthalmol 98 (2014), 1168–1176.